TotalMarketCap

InflaRx

IFRXNasdaq GermanyHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$198.947 M

$1.35 -8.78%

Close of 6 Nov 2026

As of 6 Nov 2026, InflaRx (IFRX) has a market capitalization of $198.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

72,292,859

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #247Bright Minds BiosciencesDRUG$201.3M
  2. #248Eledon PharmaceuticalsELDN$199.9M
  3. #249InflaRxIFRX$198.9M
  4. #250Pyxis OncologyPYXS$193.1M
  5. #251ProQR TherapeuticsPRQR$188.4M

What if InflaRx were worth as much as…

Open the what-if tool →

Gold $28.2T

$191,607.62

Per share 141,932× higher

Bitcoin $1.53T

$10,367.55

Per share 7,680× higher

Apple $5.02T

$34,035.71

Per share 25,212× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for InflaRx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.